bioAffinity Technologies says Japan Patent Office intends to grant patent for CyPath lung cancer test

bioAffinity Technologies says the Japan Patent Office intends to grant a patent for its CyPath lung cancer test.

Detected & updated continuously · Source: Nebula

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula